The Oral GLP-1 Pills Coming Soon: Orforglipron, Amycretin, and VK2735 Compared

The era of the weight-loss pill has arrived, and three names lead the next wave: orforglipron (already approved), amycretin, and VK2735 (both investigational). All aim to deliver the kind of weight loss previously reserved for injections, but in a swallowable form. They differ in how much weight they produce, how they’re dosed, and how far along they are. Here’s how the leading oral options compare and what to realistically expect.

Why Pills Are Such a Big Deal

Most effective weight-loss drugs have been injections, and while many people manage injections fine, a sizable group avoids treatment entirely because of needle aversion or inconvenience. An effective pill removes that barrier. The challenge has always been that GLP-1 drugs are peptides (proteins), which the digestive system tends to break down, making them hard to deliver orally. The new pills solve this in different ways, either by being small molecules that survive digestion or by using high doses to compensate.

It’s worth noting the landscape shifted recently: an oral version of semaglutide (the drug in Wegovy) was also approved for weight management, so pills are no longer hypothetical. But the three drugs below represent the most talked-about pipeline and newly approved options.

The Three Compared

Here’s how they stack up.

Orforglipron: The One That’s Here

Orforglipron (brand name Foundayo) is the front-runner because it’s actually approved and available. Its data comes from the ATTAIN-1 trial, published in the New England Journal of Medicine in 2025, which showed about 12.4% weight loss at the highest dose over 72 weeks. Its standout feature is convenience: unlike oral semaglutide, it can be taken any time of day with no food or water restrictions, because it’s a small molecule rather than a peptide. That makes it the most practical of the oral options today.

Amycretin: The High-Ceiling Contender

Amycretin is investigational but generates excitement because its injectable form produced weight loss in the low 20% range, hinting at a high ceiling. Its oral version showed about 13% in a short early trial, and because it combines two hormone pathways (GLP-1 and amylin), some believe it could ultimately outperform single-pathway pills. It’s earlier in development, heading into phase 3. Consider a hypothetical patient willing to wait for a potentially more powerful pill: amycretin is the one to watch, though its final oral efficacy over a full year isn’t yet known.

VK2735: The Flexible Option

VK2735 is notable because it’s being developed as both a pill and an injection using the same drug. Its oral tablet produced up to about 12.2% weight loss in a short 13-week trial, with weight still dropping at the end. It’s a dual GLP-1/GIP agonist (the same class as tirzepatide) and is advancing toward phase 3. The dual oral-and-injectable approach could give patients unusual flexibility.

What This Means for You Right Now

Of these three, only orforglipron is available, through its manufacturer by prescription. Amycretin and VK2735 remain investigational. TrimRx offers its own set of options, including compounded semaglutide and compounded tirzepatide plus brand injectables like Ozempic, Wegovy, Mounjaro, and Zepbound. If you’re interested in weight loss now, a provider can help you weigh what’s actually available, whether that’s an approved pill, an injection, or a compounded option.

Frequently Asked Questions

Which oral weight-loss pill is best?

Right now, orforglipron is the most relevant because it’s approved and offers flexible dosing (any time, no food rules). Amycretin may have a higher ceiling based on its injectable data, and VK2735 offers oral-and-injectable flexibility, but both are still investigational, so their final oral results aren’t confirmed.

Are pills as effective as injections?

Generally, the strongest injections still produce more weight loss than current pills. Oral options like orforglipron (about 12.4%) are effective and convenient, but the most powerful injectables reach higher figures. The gap may narrow as newer pills like amycretin mature.

Can I get these pills from TrimRx?

Orforglipron is available through its manufacturer, not TrimRx. Amycretin and VK2735 aren’t available at all yet. TrimRx offers compounded semaglutide and tirzepatide and brand injectable GLP-1 options.

To see what fits you today, you can explore the options available to you now with a licensed provider.

This information is for educational purposes and is not medical advice. Amycretin and VK2735 are investigational and not FDA approved; details and timelines may change. Consult a healthcare provider before starting any medication. Individual results may vary.